AIDS-related toxiderma;Les toxidermies au cours du SIDA

Revue Francaise d'Allergologie et d'Immunologie Clinique

Volumn 37, Issue 5, 1997, Pages 678-684

  Bocquet, H ^a   Chosidow, O ^b  

^a HENRI MONDOR HOSPITAL   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Drug rash; HIV; Toxic epidermal necrolysis

Indexed keywords

CLINDAMYCIN; DAPSONE; ETHAMBUTOL; ISONIAZID; PYRAZINAMIDE; PYRIMETHAMINE; RIFAMPICIN; SULFADIAZINE; SULFAMETHOXAZOLE; TRIMETHOPRIM;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIBIOTIC PROPHYLAXIS; ARTICLE; DRUG ERUPTION; HUMAN; PNEUMOCYSTIS PNEUMONIA; STEVENS JOHNSON SYNDROME; TOXIC EPIDERMAL NECROLYSIS; TOXOPLASMOSIS;

EID: 0030806671     PISSN: 03357457     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0335-7457(97)80066-4     Document Type: Article

References (32)

1. Abrams D., Goldman A.I., Launer C. et coll. - A comparative trial of didanosine or zalcitabine after treatment with zidovudine in patients with human immunodeficiency virus infection. N. Engl. J. Med., 1994, 330, 657-662.
2. Aguilar X., Ruiz J., Clotet B. et coll. - The use of corticosteroids in the control of adverse effects of cotrimoxazole in AIDS patients suffering from PCP. AIDS, 1991, 5, 777-778.
3. Battegay M., Opravil M. Wüthrich B. et coll. - Rash with amoxycillin - clavulanate therapy in HIV - infected patients. Lancet, 1989, ii, 1100.
4. Beumont M.G., Graziani A., Ubel P.A., MacGregor R.R. - Safety of dapsone as pneumocystis carinii pneumonia prophylaxis in human immunodeficiency virus-infected patients with allergy to trimethoprim/sulfamethoxazole. Am. J. Med., 1996, 100, 611-616.
5. Buhl R., Jaffe H.A., Holroyd K. et coll. - Systemic glutathione deficiency in symptom-free HIV-seropositive individuals. Lancet, 1989, i, 1294-1298.
6. Carr A., Penny R., Cooper D. - Efficacy and safety of rechallenge with low-dose trimethoprim-sulfamethoxazole in previously hypersensitive HIV-infected patients. AIDS, 1993, 7, 65-71.
7. Carr A., Swanson C., Penny R. et coll. - Clinical and laboratory markers of hypersensitivity to trimethoprim-sulfamethoxazole in patients with pneumocystis carinii pneumonia and AIDS. J. Infect. Dis., 1993, 167, 180-185.
8. Carr A., Tindall B., Penny R. et coll. - Patterns of multiple drug hypersensitivities in HIV-infected patients. AIDS, 1993, 7, 1532-1533.
9. Caumes E., Bocquet H., Guermonprez G. et coll. - Adverse cutaneous reactions to pyrimethamine-sulfadiazine and pyrimethamine-clindamycine in AIDS patients with toxoplasmic encephalitis. Clin. Infect. Dis., 1995, 21, 656-658.
10. Caumes E., Roudier C., Rogeaux O. et coll. - Effect of corticosteroids on the incidence of adverse cutaneous reactions to trimethoprim-sulfamethoxazole during treatment of AIDS-associated pneumocystis carinii pneumonia. Clin. Infect. Dis., 1994, 18, 319-323.
11. Chosidow O., Bourgault-Villada I., Roujeau J.C. - Drug Rashes. What are the targets of cell-mediated cytotoxicity? Arch. Dermatol., 1994, 130, 627-629.
12. Coopman S., Johnson R., Platt R. et coll. - Cutaneous diseases and drug reactions in HIV infection. N. Engl. J. Med., 1993, 328, 1670-1674.
13. Hardy W.D., Feinberg J., Finkelstein D.M. et coll. - A controlled trial of trimethoprim - sulfamethoxazole or aerosolized pentamidine for secondary prophylaxis of pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome. N. Engl. J. Med., 1992, 327, 1842-1848.
14. Hughes W., Feldman S., Chaudhary S. et coll. - Comparison of pentamidine isethionate and trimethoprim-sulfamethoxazole in treatement of pneumocystis carinii pneumonia. J. Pediatr., 1978, 92, 285-291.
15. Hughes W.T., Lafon S.W., Scott J.D., Masur H. - Adverse events associated with trimethoprim-sulfamethoxazole and atovaquone during the treatment of AIDS-related pneumocystis carinii pneumonia. J. Infect. Dis., 1995, 171, 1295-1301.
16. Jick H. - Adverse reactions to trimethoprim-sulfamethoxazole in hospitalized patients. Rev. Inf. Dis., 1982, 4, 426-428.
17. Kelly J.W., Dooley D., Lattuada C. et coll. - A severe, unusual reaction to trimethoprim-sulfamethoxazole in patients infected with human immunodeficiency virus. Clin. Infect. Dis., 1992, 14, 1034-1039.
18. Kennedy C., Pimentel J.A., Lewis D.E. et coll. - Crossover of human immunodeficiency virus-infected patients from aerolized pentamidine to trimethoprim-sulfamethoxazole : lack of hematologic toxicity and relationship of side effects to CD4+ lymphocyte count. J. Infect. Dis., 1993, 168, 314-317.
19. Lee B., Medina I., Benowitz N. et coll. - Dapsone, trimethoprim, and sulfamethoxazole plasma levels during treatment of pneumocystis pneumonia in patients with the acquired immunodeficiency syndrome. Evidence of drug interactions. Ann. Intern. Med., 1989, 110, 606-611.
20. Nunn P., Kibuga D., Gathua S. et coll. - Cutaneous hypersensitivity reactions due to thiacetazone in HIV-1 seropositive patients treated for tuberculosis. Lancet, 1991, 337, 627-630.
21. Okwera A., Whalen C., Byekwaso F. et coll. - Randomised trial of thiacetazone and rifampicin-containing regimens for pulmonary tuberculosis in HIV-infected ugandans. Lancet, 1994, 344, 1323-1328.
22. Perriens J.H., St Louis M.E., Mukadi Y.B. et coll. - Pulmonary tuberculosis in HIV-infected patients in Zaïre. A controlled trial of treatment for either 6 or 12 months. N. Engl. J. Med., 1995, 332, 779-784.
23. Rieder M., Uetrecht J., Shear N. et coll. - Diagnosis of sulfonamide hypersensitivity reactions by in vitro «rechallenge»with hydroxylamine metabolites. Ann. Intern. Med., 1989, 110, 286-289.
24. Rieder M.J., Shear N.H., Kanee A. et coll. - Prominence of slow acetylor phenotype among patients with sulfonamide hypersensitivity reactions. Clin. Pharmacol. Ther., 1991, 49, 13-17.
25. Roudier C., Caumes E., Rogeaux O. et coll. - Adverse cutaneous reactions to trimethoprim-sulfamethoxazole in patients with acquired immunodeficiency syndrome and pneumocystis carinii pneumonia. Arch. Dermatol., 1994, 130, 1383-1386.
26. Roujeau J.C., Kelly J.P., Naldi L. et coll. - Medication use and risk of Stevens-Johnson syndrome or toxic epidermal necrolysis. N. Engl. J. Med., 1995, 333, 1600-1607.
27. Rzany B., Mockenhaupt M., Stoker U. - Incidence of Stevens-Johnson syndrome and toxic epidermal necrolysis in patients with the acquired immunodeficiency syndrome in Germany. Arch. Dermatol., 1993, 129, 1059.
28. Saïag P., Caumes E., Chosidow O. et coll. - Drug-induced toxic epidermal necrolysis (Lyell syndrome) in patients infected with the human immunodeficiency virus. J. Am. Acad. Dermatol., 1992, 26, 567-574.
29. Shear N., Spielberg S., Grant D. et coll. - Differences in metabolism of sulfonamides predisposing to idiosyncratic toxicity. Ann. Intern. Med., 1986, 105, 179-184.
30. Van Der Ven A., Koopmans P., Vree T. et coll. - Adverse reactions to co-trimoxazole in HIV infection. Lancet, 1991, 338, 431-433.
31. Van Leeuwen R., Katlama C., Kitchen V. et coll. - Evaluation of safety and efficacy of 3TC (lamuvudine) in patients with asymptomatic or mildly symptomatic human immuno-deficiency virus infection: a phase I/II study. J. Infect. Dis., 1995, 171, 1166-1171.
32. Wurtz R., Abrams D., Becker S. et coll. - Anaphylactoid drug reactions to ciprofloxacin and rifampicin in HIV-infected patients. Lancet, 1989, i, 955-956